Prurigo Nodularis Treatment Market Overview

The report is titled ‘Prurigo Nodularis Treatment Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the prurigo nodularis treatment market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. Prurigo nodularis treatment market is expected to grow at a significant rate in the near future.

The global prurigo nodularis treatment market in 2020 is estimated for more than US$ 1.2 Bn and expected to reach a value of US$ 1.6 Bn by 2028 with a significant CAGR of 3.5%.

Prurigo Nodularis Treatment Market Dynamics

The global prurigo nodularis treatment market is estimated to have a steady growth during the forecast period, accounting for the robust demand for prominent orphan drugs that are capable to treat such rare diseases, the existence of numerous ongoing research and development activities in the healthcare sector, promising product pipeline, and the elevating healthcare expenditure.

Furthermore, the occurrence of this rare disease and the mounting need for better treatment of patients suffering from prurigo nodularis is also expected to favor the growth of this market.

In addition, the initiative that was taken by the regional governments, numerous non-government organizations for aiding sufficient funding to support the R & D activities are also boosting the demand for prurigo nodularis treatment.

Other socio-economic factors such as an increasing number of rare diseases and requirements for better treatment for Prurigo Nodularis also aid market growth. However, the growth of the global prurigo nodularis treatment market is hampered by the factors accounting to the shortage of expert healthcare professionals across the globe.

Accessibility to alternative treatment options, lack of regulatory framework in emerging economies, and the expensive treatment cost. on the other hand, the collaborative funding for transitional projects is expected to create opportunities for the growth of the global market. For instance, Phototherapy is used for treating numerous inflammatory skin conditions and is also considered a therapeutic alternative for patients suffering from multiple comorbidities or generalized prurigo nodularis.

Prurigo Nodularis Treatment Market Segmentation

The global prurigo nodularis treatment market is segmented on the basis of product, distribution channel, and by region.

By Product:

    Antihistamines

    Capsaicin Cream

    Corticosteroids

    Emollients

    Others

By Distribution Channel:

    Retail Pharmacies

    Hospital Pharmacies

    Online Pharmacies

By Region:

    North America

    Europe

    Asia Pacific

    Latin America

    Middle East

    Africa

Prurigo Nodularis Treatment Market Pipeline Drugs Overview

The global prurigo nodularis treatment market also witnessed growth owing to the availability of drugs in the product pipeline. These drugs account for the KPL-716, under the manufacturing of Kiniksa Pharmaceuticals, Ltd., which is in Phase 2 and is expected to launch by October 2020.

Another drug named Nalbuphine ER Tablets, produced under Trevi Therapeutics, is also expected to cure Prurigo Nodularis. This drug is in Phase 2      with its expected official launch in March 2021. Last but not the least, Menlo Therapeutics Inc. is also preparing to launch a drug named 5mg Serlopitant Tablets for the treatment of Pruritis. This drug is in its Phase 3 and is expected to be launch in the market by March 2020.

Prurigo Nodularis Treatment Market Competitive Landscape

Key players operating in the global prurigo nodularis treatment market include Bayer AG, GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd.

Regional Segmentation

On the basis of region, the prurigo nodularis treatment market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

MMC Overview on Prurigo Nodularis Treatment Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the Prurigo Nodularis Treatment market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Prurigo Nodularis Treatment

•    Advantages of Prurigo Nodularis Treatment

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Prurigo Nodularis Treatment Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Prurigo Nodularis Treatment Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Prurigo Nodularis Treatment Market Snapshot

2.4.    Global Prurigo Nodularis Treatment Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Prurigo Nodularis Treatment Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Prurigo Nodularis Treatment Market, By Product

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Product

3.1.2.    BPS Analysis, By Product

3.2.    Market Revenue (US$Mn) Forecast, By Product

3.2.1.    Antihistamines

3.2.2.    Capsacin Cream

3.2.3.    Corticosteroids

3.2.4.    Emollients

3.2.5.    Others

3.3.    Global Prurigo Nodularis Treatment Market Attractiveness Index, By Product

4.    Global Prurigo Nodularis Treatment Market, By Distribution Channel

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Distribution Channel

4.1.2.    BPS Analysis, By Distribution Channel

4.2.    Market Revenue (US$Mn) Forecast, By Distribution Channel

4.2.1.    Retail Pharmacies

4.2.2.    Hospital Pharmacies

4.2.3.    Online Pharmacies

4.3.    Global Prurigo Nodularis Treatment Market Attractiveness Index, By Distribution Channel

5.    Global Prurigo Nodularis Treatment Market, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East

5.2.6.    Africa

5.3.    Global Prurigo Nodularis Treatment Market Attractiveness Index, By Region

6.    North America Prurigo Nodularis Treatment Market Analysis and Forecast, 2020–2028

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) Forecast, By Country

6.2.1.    U.S. Prurigo Nodularis Treatment Market

6.2.2.    Canada Prurigo Nodularis Treatment Market

6.3.    North America Prurigo Nodularis Treatment Market, By Product

6.3.1.    Antihistamines

6.3.2.    Capsaicin Cream

6.3.3.    Corticosteroids

6.3.4.    Emollients

6.3.5.    Others

6.4.    North America Prurigo Nodularis Treatment Market, By Distribution Channel

6.4.1.    Retail Pharmacies

6.4.2.    Hospital Pharmacies

6.4.3.    Online Pharmacies

6.5.    North America Prurigo Nodularis Treatment Market Attractiveness Index

6.5.1.    By Country

6.5.2.    By Distribution Channel

6.5.3.    By Product

7.    Latin America Prurigo Nodularis Treatment Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) Forecast, By Country

7.2.1.    Brazil Prurigo Nodularis Treatment Market

7.2.2.    Mexico Prurigo Nodularis Treatment Market

7.2.3.    Argentina Prurigo Nodularis Treatment Market

7.2.4.    Rest Of Latin America Prurigo Nodularis Treatment Market

7.3.    Latin America Prurigo Nodularis Treatment Market, By Product

7.3.1.    Antihistamines

7.3.2.    Capsaicin Cream

7.3.3.    Corticosteroids

7.3.4.    Emollients

7.3.5.    Others

7.4.    Latin America Prurigo Nodularis Treatment Market, By Distribution Channel

7.4.1.    Retail Pharmacies

7.4.2.    Hospital Pharmacies

7.4.3.    Online Pharmacies

7.5.    Latin America Prurigo Nodularis Treatment Market Attractiveness Index

7.5.1.    By Country

7.5.2.    By Distribution Channel

7.5.3.    By Product

8.    Europe Prurigo Nodularis Treatment Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    U.K. Prurigo Nodularis Treatment Market

8.2.2.    Germany Prurigo Nodularis Treatment Market

8.2.3.    Italy Prurigo Nodularis Treatment Market

8.2.4.    France Prurigo Nodularis Treatment Market

8.2.5.    Spain Prurigo Nodularis Treatment Market

8.2.6.    Russia Prurigo Nodularis Treatment Market

8.2.7.    Poland Prurigo Nodularis Treatment Market

8.2.8.    BENELUX Prurigo Nodularis Treatment Market

8.2.9.    NORDIC Prurigo Nodularis Treatment Market

8.2.10.    Rest Of Europe Prurigo Nodularis Treatment Market

8.3.    Europe Prurigo Nodularis Treatment Market, By Product

8.3.1.    Antihistamines

8.3.2.    Capsaicin Cream

8.3.3.    Corticosteroids

8.3.4.    Emollients

8.3.5.    Others

8.4.    Europe Prurigo Nodularis Treatment Market, By Distribution Channel

8.4.1.    Retail Pharmacies

8.4.2.    Hospital Pharmacies

8.4.3.    Online Pharmacies

8.5.    Europe Prurigo Nodularis Treatment Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Distribution Channel

8.5.3.    By Product

9.    Asia Pacific Prurigo Nodularis Treatment Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    China Prurigo Nodularis Treatment Market

9.2.2.    India Prurigo Nodularis Treatment Market

9.2.3.    Japan Prurigo Nodularis Treatment Market

9.2.4.    Australia And New Zealand Prurigo Nodularis Treatment Market

9.2.5.    South Korea Prurigo Nodularis Treatment Market

9.2.6.    ASEAN Prurigo Nodularis Treatment Market

9.2.7.    Rest Of Asia Pacific Prurigo Nodularis Treatment Market

9.3.    Asia Pacific Prurigo Nodularis Treatment Market, By Product

9.3.1.    Antihistamines

9.3.2.    Capsaicin Cream

9.3.3.    Corticosteroids

9.3.4.    Emollients

9.3.5.    Others

9.4.    Asia Pacific Prurigo Nodularis Treatment Market, By Distribution Channel

9.4.1.    Retail Pharmacies

9.4.2.    Hospital Pharmacies

9.4.3.    Online Pharmacies

9.5.    Asia Pacific Prurigo Nodularis Treatment Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Distribution Channel

9.5.3.    By Product

10.    Middle East Prurigo Nodularis Treatment Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    GCC Countries Prurigo Nodularis Treatment Market

10.2.2.    Israel Prurigo Nodularis Treatment Market

10.2.3.    Oman Prurigo Nodularis Treatment Market

10.2.4.    Rest Of Middle East Prurigo Nodularis Treatment Market

10.3.    Middle East Prurigo Nodularis Treatment Market, By Product

10.3.1.    Antihistamines

10.3.2.    Capsaicin Cream

10.3.3.    Corticosteroids

10.3.4.    Emollients

10.3.5.    Others

10.4.    Middle East Prurigo Nodularis Treatment Market, By Distribution Channel

10.4.1.    Retail Pharmacies

10.4.2.    Hospital Pharmacies

10.4.3.    Online Pharmacies

10.5.    Middle East Prurigo Nodularis Treatment Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Distribution Channel

10.5.3.    By Product

11.    Africa Prurigo Nodularis Treatment Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (Us$Mn) Forecast, By Country

11.2.1.    South Africa Prurigo Nodularis Treatment Market

11.2.2.    Egypt Prurigo Nodularis Treatment Market

11.2.3.    North Africa Prurigo Nodularis Treatment Market

11.2.4.    Rest Of Africa Prurigo Nodularis Treatment Market

11.3.    Africa Prurigo Nodularis Treatment Market, By Product

11.3.1.    Antihistamines

11.3.2.    Capsaicin Cream

11.3.3.    Corticosteroids

11.3.4.    Emollients

11.3.5.    Others

11.4.    Africa Prurigo Nodularis Treatment Market, By Distribution Channel

11.4.1.    Retail Pharmacies

11.4.2.    Hospital Pharmacies

11.4.3.    Online Pharmacies

11.5.    Africa Prurigo Nodularis Treatment Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Distribution Channel

11.5.3.    By Product

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    Bayer AG  

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    GlaxoSmithKline plc

13.3.3.    Johnson & Johnson Services Inc.

13.3.4.    Merck & Co. Inc.

13.3.5.    Pfizer Inc.

13.3.6.    Sanofi SA

13.3.7.    Takeda Pharmaceutical Company Limited

13.3.8.    Teva Pharmaceutical Industries Ltd.

14.    Acronyms